|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walker S: Updates in non-small cell lung
cancer. Clin J Oncol Nurs. 12:587–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shao Y, Liang B, Long L and Jiang SJ:
Diagnostic MicroRNA biomarker discovery for non-small-cell lung
cancer adenocarcinoma by integrative bioinformatics analysis.
Biomed Res Int. 2017:25630852017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu C, Zhu W, Qian J, He S, Wu C, Chen Y
and Shu Y: WT1 promotes invasion of NSCLC via suppression of CDH1.
J Thorac Oncol. 8:1163–1169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Mukherjee K, Vats A, Ghosh D and Pillai
SK: Data analysis and network study of non-small-cell lung cancer
biomarkers. Advances in Computational Intelligence. Sahana S and
Bhattacharjee V: Springer; Singapore: pp. 265–272. 2020, View Article : Google Scholar
|
|
6
|
Liao Y, Cao L, Wang F and Pang R:
miR-605-5p promotes invasion and proliferation by targeting TNFAIP3
in non-small-cell lung cancer. J Cell Biochem. 121:779–787. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Wang X, Zhang J, Lam EK, Shin VY,
Cheng AS, Yu J, Chan FK, Sung JJ and Jin HC: Warburg effect
revisited: An epigenetic link between glycolysis and gastric
carcinogenesis. Oncogene. 29:442–450. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meienhofer Mc, De Medicis E, Cognet M and
Kahn A: Regulation of genes for glycolytic enzymes in cultured rat
hepatoma cell lines. Eur J Biochem. 169:237–243. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brand K: Aerobic glycolysis by
proliferating Cells: Protection against oxidative stress at the
expense of energy yield. J Bioenerg Biomembr. 29:355–364. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gillies RJ, Robey I and Gatenby RA: Causes
and consequences of increased glucose metabolism of cancers. J Nucl
Med. 49 (Suppl 2):24S–42S. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lang N, Wang C, Zhao J, Shi F, Wu T and
Cao H: Long non-coding RNA BCYRN1 promotes glycolysis and tumor
progression by regulating the miR-149/PKM2 axis in non-small-cell
lung cancer. Mol Med Rep. 21:1509–1516. 2020.PubMed/NCBI
|
|
13
|
Gan J, Li S, Meng Y, Liao Y, Jiang M, Qi
L, Li Y and Bai Y: The influence of photodynamic therapy on the
Warburg effect in esophageal cancer cells. Lasers Med Sci.
35:1741–1750. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L,
Geng Q, Pan H, Yan M and Yao M: OTUB2 stabilizes U2AF2 to promote
the Warburg effect and tumorigenesis via the AKT/mTOR signaling
pathway in non-small cell lung cancer. Theranostics. 9:179–195.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi J, Wang H, Feng W, Huang S, An J, Qiu
Y and Wu K: MicroRNA-130a targeting hypoxia-inducible factor 1
alpha suppresses cell metastasis and Warburg effect of NSCLC cells
under hypoxia. Life Sci. 255:1178262020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu T and Yin H: PDK1 promotes tumor cell
proliferation and migration by enhancing the Warburg effect in
non-small cell lung cancer. Oncol Rep. 37:193–200. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park YY, Kim SB, Han HD, Sohn BH, Kim JH,
Liang J, Lu Y, Rodriguez-Aguayo C, Lopez-Berestein G, Mills GB, et
al: Tat-activating regulatory DNA-binding protein regulates
glycolysis in hepatocellular carcinoma by regulating the platelet
isoform of phosphofructokinase through microRNA 520. Hepatology.
58:182–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang YM, Liu JK and Wong TY: The DNA
excision repair system of the highly radioresistant bacterium
Deinococcus radiodurans is facilitated by the pentose phosphate
pathway. Mol Microbiol. 48:1317–1323. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Y, Xu Q, Ji D, Wei Y, Chen H, Li T,
Wan B, Yuan L, Huang R and Chen G: Inhibition of pentose phosphate
pathway suppresses acute myelogenous leukemia. Tumour Biol.
37:6027–6034. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim NH, Cha YH, Lee J, Lee SH, Yang JH,
Yun JS, Cho ES, Zhang X, Nam M, Kim N, et al: Snail reprograms
glucose metabolism by repressing phosphofructokinase PFKP allowing
cancer cell survival under metabolic stress. Nat Commun.
8:143742017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Zhang P, Zhong J, Tan M, Ge J, Tao
L, Li Y, Zhu Y, Wu L, Qiu J and Tong X: The platelet isoform of
phosphofructokinase contributes to metabolic reprogramming and
maintains cell proliferation in clear cell renal cell carcinoma.
Oncotarget. 7:27142–27157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: An integrated TCGA pan-cancer clinical data resource to
drive high-quality survival outcome analytics. Cell.
173:400–416.e11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Therneau T M and Grambsch P M: Modeling
Survival Data: Extending the Cox Model. Springer; New York, NY:
2000, View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mor I, Cheung EC and Vousden KH: Control
of glycolysis through regulation of PFK1: Old friends and recent
additions. Cold Spring Harb Symp Quant Biol. 76:211–216. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang C, Chen S, Wang Y, Liu X, Hu F, Sun J
and Yuan H: Lipase-triggered water-responsive ‘Pandora's Box’ for
cancer therapy: Toward induced neighboring effect and enhanced drug
penetration. Adv Mater. 30:e17064072018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang D, Zhao X, Zhang L, Wang Z and Wang
C: Identification of hub genes to regulate breast cancer metastasis
to brain by bioinformatics analyses. J Cell Biochem. 120:9522–9531.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JH, Liu R, Li J, Zhang C, Wang Y, Cai
Q, Qian X, Xia Y, Zheng Y, Piao Y, et al: Stabilization of
phosphofructokinase 1 platelet isoform by AKT promotes
tumorigenesis. Nat Commun. 8:9492017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen G, Liu H, Zhang Y, Liang J, Zhu Y,
Zhang M, Yu D, Wang C and Hou J: Silencing PFKP inhibits
starvation-induced autophagy, glycolysis, and epithelial
mesenchymal transition in oral squamous cell carcinoma. Exp Cell
Res. 370:46–57. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wegener G and Krause U: Different modes of
activating phosphofructokinase, a key regulatory enzyme of
glycolysis, in working vertebrate muscle. Biochem Soc Trans.
30:264–270. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moon JS, Kim HE, Koh E, Park SH, Jin WJ,
Park BW, Park SW and Kim KS: Krüppel-like factor 4 (KLF4) activates
the transcription of the gene for the platelet isoform of
phosphofructokinase (PFKP) in breast cancer. J Biol Chem.
286:23808–23816. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yi W, Clark PM, Mason DE, Keenan MC, Hill
C, Goddard WA III, Peters EC, Driggers EM and Hsieh-Wilson LC:
Phosphofructokinase 1 glycosylation regulates cell growth and
metabolism. Science. 337:975–980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang J, Li J, Le Y, Zhou C, Zhang S and
Gong Z: PFKL/miR-128 axis regulates glycolysis by inhibiting AKT
phosphorylation and predicts poor survival in lung cancer. Am J
Cancer Res. 6:473–485. 2016.PubMed/NCBI
|
|
36
|
Tam WL and Weinberg RA: The epigenetics of
epithelial-mesenchymal plasticity in cancer. Nat Med. 19:1438–1449.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu
Y, Yao Y and Li D: The epithelial to mesenchymal transition (EMT)
and cancer stem cells: Implication for treatment resistance in
pancreatic cancer. Mol Cancer. 16:522017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ma P, Tang WG, Hu JW, Hao Y, Xiong LK,
Wang M, Liu H, Bo WH and Yu KH: HSP4 triggers
epithelial-mesenchymal transition and promotes motility capacities
of hepatocellular carcinoma cells via activating AKT. Liver Int.
40:1211–1223. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xiao Y, Xie Q, Qin Q, Liang Y, Lin H and
Zeng D: Upregulation of SOX11 enhances tamoxifen resistance and
promotes epithelial-to-mesenchymal transition via slug in MCF-7
breast cancer cells. J Cell Physiol. 235:7295–7308. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang L, Yu Y, Xiong Z, Chen H, Tan B and
Hu H: Downregulation of SEMA4C inhibit epithelial-mesenchymal
transition (EMT) and the invasion and metastasis of cervical cancer
cells via inhibiting transforming growth factor-beta 1
(TGF-β1)-induced hela cells p38 mitogen-activated protein kinase
(MAPK) activation. Med Sci Monit. 26:e9181232020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo
F, Lyssiotis CA, Aldape K, Cantley LC, Lu Z, et al:
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2
promotes the Warburg effect. Nat Cell Biol. 14:1295–1304. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu L, Wang Y, Bai R, Yang K and Tian Z:
MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α
regulation. Oncogenesis. 6:e3182017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Akram M: Mini-review on glycolysis and
cancer. J Cancer Educ. 28:454–457. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ganapathy-Kanniappan S: Molecular
intricacies of aerobic glycolysis in cancer: Current insights into
the classic metabolic phenotype. Crit Rev Biochem Mol Biol.
53:667–682. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wan W, Peng K, Li M, Qin L, Tong Z, Yan J,
Shen B and Yu C: Histone demethylase JMJD1A promotes urinary
bladder cancer progression by enhancing glycolysis through
coactivation of hypoxia inducible factor 1α. Oncogene.
36:3868–3877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu H, Zeng Y, Liu L, Gao Q, Jin S, Lan Q,
Lai W, Luo X, Wu H, Huang Y and Chu Z: PRL-3 improves colorectal
cancer cell proliferation and invasion through IL-8 mediated
glycolysis metabolism. Int J Oncol. 51:1271–1279. 2017. View Article : Google Scholar : PubMed/NCBI
|
